Jøhnke H, Vach W, Norberg L A, Bindslev-Jensen C, Høst A, Andersen K E
Department of Dermato-venereology, Odense University Hospital, University of Southern Denmark, DK-5000 Odense, Denmark.
Br J Dermatol. 2005 Aug;153(2):352-8. doi: 10.1111/j.1365-2133.2005.06491.x.
Epidemiological studies have shown different estimates of the frequency of atopic eczema (AE) in children. This may be explained by several factors including variations in the definition of AE, study design, age of study group, and the possibility of a changed perception of atopic diseases. The role of IgE sensitization in AE is a matter of debate.
To determine the prevalence and cumulative incidence of AE in a group of unselected infants followed prospectively from birth to 18 months of age using different diagnostic criteria; to evaluate the agreement between criteria; and to describe the association between atopic heredity and postnatal sensitization, respectively, and the development of AE according to the different diagnostic criteria.
During a 1-year period a consecutive series of 1095 newborns and their parents were approached at the maternity ward at the Odense University Hospital, Denmark and a cohort of 562 newborns was established. Infants were examined and followed prospectively from birth and at 3, 6, 9, 12 and 18 months of age. AE was diagnosed using four different criteria, the Hanifin and Rajka criteria, the Schultz-Larsen criteria, the Danish Allergy Research Centre (DARC) criteria developed for this study and doctor-diagnosed visible eczema with typical morphology and atopic distribution. Additionally, the U.K. diagnostic criteria based on a questionnaire were used at 1 year of age. Agreement between the four criteria was analysed at each time point and over time, and agreement between the four criteria and the U.K. questionnaire criteria was analysed.
The cumulative 1-year prevalence of AE using the Hanifin and Rajka criteria was 9.8% (95% confidence interval, CI 7-13%), for the Schultz-Larsen criteria it was 7.5% (95% CI 5-10%), for the DARC criteria 8.2% (95% CI 6-11%), for visible eczema 12.2% (95% CI 9-16%) and for the U.K. criteria 7.5% (95% CI 5-10%). The pairwise agreement between criteria showed good agreement, with rates varying between 93% and 97% and kappa scores between 0.6 and 0.8. Agreement analysis of diagnoses between the four criteria demonstrated that cumulative incidences showed better agreement than point prevalence values.
Agreement between different criteria for diagnosing AE was acceptable, but the mild cases constituted a diagnostic problem, although they were in the minority. Repeated examinations gave better agreement between diagnostic criteria than just one examination. Atopic heredity was less predictive for AE than sensitization to common food and inhalant allergens in early childhood.
流行病学研究显示,对儿童特应性皮炎(AE)发病率的估计各不相同。这可能由多种因素导致,包括AE定义的差异、研究设计、研究组年龄以及对特应性疾病认知的变化可能性。IgE致敏在AE中的作用存在争议。
使用不同诊断标准,确定一组从出生到18个月大的未筛选婴儿中AE的患病率和累积发病率;评估各标准之间的一致性;并分别描述特应性遗传与出生后致敏之间的关联,以及根据不同诊断标准AE的发展情况。
在1年的时间里,丹麦欧登塞大学医院产科病房连续接触了1095名新生儿及其父母,并建立了一个由562名新生儿组成的队列。从出生开始,以及在3、6、9、12和18个月大时对婴儿进行前瞻性检查。使用四种不同标准诊断AE,即哈尼芬和拉伊卡标准、舒尔茨 - 拉森标准、为本研究制定的丹麦过敏研究中心(DARC)标准以及医生诊断的具有典型形态和特应性分布的可见湿疹。此外,在1岁时使用基于问卷的英国诊断标准。在每个时间点及随时间分析四种标准之间的一致性,并分析四种标准与英国问卷标准之间的一致性。
使用哈尼芬和拉伊卡标准,AE的1年累积患病率为9.8%(95%置信区间,CI 7 - 13%);舒尔茨 - 拉森标准为7.5%(95% CI 5 - 10%);DARC标准为8.2%(95% CI 6 - 11%);可见湿疹为12.2%(95% CI 9 - 16%);英国标准为7.5%(95% CI 5 - 10%)。各标准之间的两两一致性显示出良好的一致性,比率在93%至97%之间,kappa值在0.6至0.8之间。四种标准之间诊断的一致性分析表明,累积发病率的一致性比点患病率值更好。
不同AE诊断标准之间的一致性是可以接受的,但轻度病例构成了诊断难题,尽管它们占少数。重复检查比单次检查在诊断标准之间产生了更好的一致性。与儿童早期对常见食物和吸入性过敏原的致敏相比,特应性遗传对AE的预测性较低。